ArticleScientific reports2022
Heterogenous nanocomposite catalysts with rhenium nanostructures for the catalytic reduction of 4-nitrophenol.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 21 citations in OpenAlex.
- Catalytic reductions of nitroaromatic compounds over heterogeneous catalysts with rhenium sub-nanostructures.Scientific reports · 2023Article
- Catalytic Reduction of p-Nitrophenol on MnONanomaterials (Basel, Switzerland) · 2023Article
- Biofuels and Nanocatalysts: Python Boosting Visualization of Similarities.Materials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Stable and efficient heterogenous nanocatalysts for the reduction of 4-nitrophenol (4-NP) has attracted much attention in recent years. In this context, a unique and efficient in situ approach is used for the production of new polymeric nanocomposites (pNCs) containing rhenium nanostructures (ReNSs). These rare materials should facilitate the catalytic decomposition of 4-NP, in turn ensuring increased catalytic activity and stability. These nanomaterials were analyzed using Fourier-Transformation Infrared spectroscopy (FT-IR), transmission electron microscopy (TEM), and X-ray powder diffraction (XRD). The efficiency of the catalytic reaction was estimated based on the acquired UV-Vis spectra, which enabled the estimation of the catalytic activity using pseud-first order modelling. The applied method resulted in the successful production and efficient loading of ReNSs in the polymeric matrices. Amino functionalities played a primary role in the reduction process. Moreover, the functionality that is derived from 1.1'-carbonyl imidazole improved the availability of the ReNSs, which resulted in 90% conversion of 4-NP with a maximum rate constant of 0.29 min
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.